The fact that Kv1.3 channel is functionally restricted regarding tissue distribution together with the improvement of experimental autoimmune encephalomyelitis [38] and delayed type hypersensitivity in animal models without causing obvious side effects has made Kv1.3 an interesting therapeutic target [2,39,40]. Here, KCNA3 is linked to experimental autoimmune encephalomyelitis.